Basic information Supplier

Ataciguat

Basic information Supplier
254877-67-3 Basic informationMore
USE
Ataciguat, formerly referred to as HMR-1766, a novel anthranilic acid derivative, belongs to a new structural class of sGC activators capable of activating the oxidized form of sGC. Ataciguat has been shown to improve endothelial function and to reduce platelet activation in exptl. diabetes. Chronic regular treatment with sGC activators such as ataciguat could therefore eventually constitute an effective therapy targeting deficient NO/cGMP signaling in hypertension, peripheral and coronary artery disease, heart failure, thrombosis and erectile dysfunction.

Browse by Nationality 254877-67-3 Suppliers >Global suppliers

Beijing (6) Shanghai (22) Guangdong (2) Zhejiang (1) Fujian (1) Hubei (1) Shandong (1) Henan (1) Anhui (1) Jiangsu (3) Other (2) Member (41) All (41)
Please select the suppliers
Recommend You Select Member Companies
  • Company Name:J & K SCIENTIFIC LTD.
  • Tel:010-82848833 400-666-7788
  • Products Intro:Product Name:Ataciguat
    CAS:254877-67-3
    Package:50Mg,5Mg More...
  • CB Index:76
  • Related Information:Catalog(96815)
  •  
  • Company Name:Shanghai EFE Biological Technology Co., Ltd.
  • Tel:021-65675885 18964387627
  • Products Intro:Product Name:Ataciguat
    CAS:254877-67-3
    Purity:95% Package:1mg;5mg;10mg More...
  • CB Index:58
  • Related Information:Catalog(9708)
  •  
1 2 3 4 5 6